BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28443693)

  • 1. Confounder factors masking a Leydig-cell ovarian tumor in a post-menopausal woman treated for androgen-positive receptor breast cancer.
    Moura FS; Costa-Barbosa FA; Leao SC; Nicolau SM; Kater CE; Monteagudo PT
    Gynecol Endocrinol; 2017 Sep; 33(9):675-679. PubMed ID: 28443693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
    Souto SB; Baptista PV; Braga DC; Carvalho D
    Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare ovarian Leydig cell tumor (hilar type) causing virilization in a postmenopausal woman.
    Vouza E; Kairi-Vassilatou E; Kleanthis CK; Hasiakos N; Salakos N; Kondi-Pafiti A
    Eur J Gynaecol Oncol; 2011; 32(5):557-9. PubMed ID: 22053675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A very rare cause of virilization in childhood: ovarian Leydig cell tumor.
    Arhan E; Cetinkaya E; Aycan Z; Aslan AT; Yücel H; Vidinlisan S
    J Pediatr Endocrinol Metab; 2008 Feb; 21(2):181-3. PubMed ID: 18422031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure leydig cell tumour of the ovary in a post-menopausal patient with severe hyperandrogenism and erythrocytosis.
    Yetkin DO; Demirsoy ET; Kadioglu P
    Gynecol Endocrinol; 2011 Apr; 27(4):237-40. PubMed ID: 20518640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
    Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
    Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virilization due to androgen hypersecretion in a patient with ovarian leydig cell tumor: diagnostic and psychosocial implications.
    Juniarto AZ; Setiawati BA; Ediati A; van der Zwan YG; Looijenga LH; de Jong FH; Dessens A; Drop SL; Faradz SM
    Acta Med Indones; 2013 Apr; 45(2):130-5. PubMed ID: 23770793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
    Sanz OA; Martinez PR; Guarch RT; Goñi MJ; Alcazar JL
    Maturitas; 2007 Jun; 57(2):214-6. PubMed ID: 17289310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
    Palha A; Cortez L; Tavares AP; Agapito A
    BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Virilization caused by an ovarian tumor. Report of one case].
    Salman M P; Cuello F M; Kolbach M; Gejman R; Arteaga U E
    Rev Med Chil; 2011 Aug; 139(8):1066-70. PubMed ID: 22215338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-Onset Type 2 Diabetes and Virilization in a Benign Sex Cord Tumor.
    Feiz F; Tehranian A; Heidary SS; Seifollahi A
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):S89-S91. PubMed ID: 28666491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Leydig cell tumor of the ovary resulting in extreme hyperandrogenism, erythrocytosis, and recurrent pulmonary embolism.
    Kozan P; Chalasani S; Handelsman DJ; Pike AH; Crawford BA
    J Clin Endocrinol Metab; 2014 Jan; 99(1):12-7. PubMed ID: 24152686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian tumors secreting androgens: an infrequent cause of hyperandrogenism.
    Perez Lana M; Demayo S; Monastero A; Nolting M
    Minerva Ginecol; 2019 Feb; 71(1):72-77. PubMed ID: 30291701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ovarian Leydig cell tumor].
    Tönnies P; Mlynek-Kersjes ML; Gellén J; Watermann D
    Zentralbl Gynakol; 1997; 119(5):241-5. PubMed ID: 9281260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
    Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
    Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
    Hirschberg AL
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult symptomatic bilateral pure Leydig cell tumors in a postmenopausal woman: a case report.
    Hussain SA; Dubil EA; De Luca-Johnson JN; Johnston M
    Gynecol Endocrinol; 2021 Jul; 37(7):672-675. PubMed ID: 34137345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative venous blood sampling to localize a small androgen-producing ovarian tumor.
    Bohlmann MK; Rabe T; Sinn HP; Strowitzki T; Von Wolff M
    Gynecol Endocrinol; 2005 Sep; 21(3):138-41. PubMed ID: 16335905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian Leydig Cell Tumor Associated with Recurrent Torsion and Virilization in an Adolescent Patient.
    Roth L; Smith AK; Buza N; Coons B; Stitelman D; Vash-Margita A
    J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):217-219. PubMed ID: 38110028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperandrogenism caused by ovarian Leydig cell tumour: finding the needle in a haystack.
    Tong CV; Tai YT
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33318251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.